A Two-Year Double-masked, Randomized, Sham-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of Ultevursen in Subjects with Retinitis Pigmentosa (RP) due to Mutations in Exon 13 of the USH2A Gene (LUNA)

Principal Investigator

Dr Jasmina Cehajic- Kapetanovic

Contact us

Email: ERGO@ouh.nhs.uk

IRAS number

1010743